Elevated levels of I-FABP in children may signal intestinal barrier dysfunction, a key feature of the imbalance of the gut–liver axis in MASLD in show Figure 2. This evidence concerns the gene FABP2 and metabolic dysfunction-associated steatotic liver disease.